Open AccessNon-adherence to colchicine treatment is a common misevaluation in familial Mediterranean fever
Author(s) -
Emre Tekgöz,
Seda Çolak,
Fatma İlknur Çınar,
Sedat Yılmaz,
Muhammet Çınar
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2102-328
Subject(s) - medicine , familial mediterranean fever , colchicine , rheumatology , observational study , physical therapy , disease
Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disease that requires lifelong colchicine treatment. Colchicine is the mainstay of the treatment, which decreases the frequency and the severity of recurrent FMF attacks and prevents the development of amyloidosis. This study aimed to investigate the rates of colchicine treatment adherence in patients with FMF and the factors related to treatment non-adherence.